Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Clot Retraction and Fibrinolysis
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Enhancing Clinical Reasoning in Surgical Education: A Randomized Crossover Trial on AI-Generated Individual Feedback for Key Feature Question-Based Online Assignments.
ActiTect: a generalizable machine learning pipeline for REM sleep behavior disorder screening through standardized actigraphy.
Reciprocal Relationship Between Cardiovascular Risk and Attainment of Blood Pressure and Cholesterol Targets in Users of a Mobile Health App.
Related Experiment Video
Updated: Jun 5, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Digital Technologies in Hereditary Coagulation Disorders: A Systematic Review.
Fabian Kahl1, Maximilian Kapsecker1,2, Leon Nissen1
1Institute for Digital Medicine, University Hospital Bonn, Bonn, Germany.
Digital technologies, including artificial intelligence (AI), are increasingly used for hereditary blood disorders. While AI aids diagnosis and treatment, more intervention studies are needed to fully realize their potential in managing these conditions.
Area of Science:
- Hematology
- Medical Informatics
- Digital Health
Background:
- Systematic review of digital technologies in hereditary blood coagulation disorders.
- Focus on prevention, diagnosis, and treatment applications.
- Addresses hemophilia A, hemophilia B, and von Willebrand disease.
Approach:
- PRISMA guidelines followed for systematic review.
- PubMed search conducted January 29, 2024.
- Inclusion criteria: 2014-present, English, actual digital tool application, hereditary coagulation disorders, human data (≥3 subjects).
Key Points:
- 21 articles met inclusion criteria from 2,843 initial searches.
- 12 articles focused on artificial intelligence (AI); 9 on digital applications.
- AI predominantly used for diagnosis and treatment; digital applications mainly for treatment.
Conclusions:
- Growing use of AI and digital applications in managing hereditary coagulation disorders.
- AI enhances diagnostic accuracy and treatment personalization.
- Digital applications improve patient care and engagement, but further research is needed due to study limitations.

